broke out in hives on truck, legs and arms; Swelling in my fingers, hands and feet; Extreme muscle and joint pain; Extreme muscle and joint pain; sore throat; white tongue; low grade fever; chills; Other symptoms worsened through day 7 post vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Sep2021 16:00 (Lot number: 30145BA) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing); "Raynauds disease" (unspecified if ongoing). Concomitant medication(s) included: XYZAL taken for hypersensitivity. Past drug history included: Hydroxicholoquine, reaction(s): "Known allergies Hydroxicholoquine"; Methotrexate, reaction(s): "Known allergies methotrexate". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6203, Location of injection: Arm Left), administration date: 08Mar2021, when the patient was 47 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9264, Location of injection: Arm Left), administration date: 15Feb2021, when the patient was 47 years old, for Covid-19 immunization. The following information was reported: URTICARIA (non-serious) with onset 29Sep2021, outcome "recovering", described as "broke out in hives on truck, legs and arms"; PERIPHERAL SWELLING (non-serious) with onset 29Sep2021, outcome "recovering", described as "Swelling in my fingers, hands and feet"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 29Sep2021, outcome "recovering" and all described as "Extreme muscle and joint pain"; OROPHARYNGEAL PAIN (non-serious) with onset 29Sep2021, outcome "recovering", described as "sore throat"; TONGUE DISCOLOURATION (non-serious) with onset 29Sep2021, outcome "recovering", described as "white tongue"; PYREXIA (non-serious) with onset 29Sep2021, outcome "recovering", described as "low grade fever"; CHILLS (non-serious) with onset 29Sep2021, outcome "recovering", described as "chills"; CONDITION AGGRAVATED (non-serious) with onset 29Sep2021, outcome "recovering", described as "Other symptoms worsened through day 7 post vaccine". The events "broke out in hives on truck, legs and arms", "swelling in my fingers, hands and feet", "extreme muscle and joint pain", "extreme muscle and joint pain", "sore throat", "white tongue", "low grade fever", "chills" and "other symptoms worsened through day 7 post vaccine" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of urticaria, peripheral swelling, myalgia, arthralgia, oropharyngeal pain, tongue discolouration, pyrexia, chills, condition aggravated.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient was treated with 40 mg prednisone daily.  Follow-up attempts are completed. No further information is expected.